Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multispectral Optoacoustic Imaging Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases: a Single Center Proof of Concept Study

NCT03923881 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03923881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multispectral Optoacoustic Imaging Using Cetuximab-800CW for Detection of Cervical Lymph Node Metastases: a Single Center Proof of Concept Study
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Unknown status
Start date
April 11, 2019
Completion date
September 30, 2021
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, oral cancer